至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Targeting SKAP2 restores sperm motility and morphology through modulating mitochondrial organization and cytoskeletal remodeling

Signal transduction and targeted therapy. 2025-12; 
Shiming Gan, Lin Yin, Jiaming Zhou, Sisi Li, Shumin Zhou, Xiaotong Yang, Rui Liu, Xu Fan, Yangyang Li, Zhendong Yao, Jingshou Chen, Peiran Hu, Wenjing Xiong, Yuan Yuan, Yujiao Wen, Youjiang Li, Ge Jin, Jianzhong Sheng, Yuzhen Gao, Hefeng Huang, Chen Zhang
Products/Services Used Details Operation
Proteins, Expression, Isolation and Analysis The protein marker is provided by GenScript Corporation (Cat# MM1397-500). Get A Quote

摘要

Sperm motility and morphology are indispensable for sperm-egg interaction and successful fertilization. However, the RNA splicing mechanisms in an m6A-dependent manner regulating spermiogenesis-related genes remain poorly defined, and targeted therapy strategies to restore impaired sperm motility and morphology are lacking. In this study, we identify heterogeneous nuclear ribonucleoprotein R (hnRNPR) as a critical m6A-dependent splicing mediator. Pathogenic mutations in HNRNPR cause sperm motility decline, morphological abnormality, and male infertility in both humans and mice. Mechanistically, Hnrnpr mutation disrupts m6A-dependent splicing of Skap2 pre-mRNA, thus impairing cytoskeletal structure and mitochond... More

关键词